XML 17 R42.htm IDEA: XBRL DOCUMENT
v2.4.0.6

Segments of Business and Geographic Areas (Details 1) (USD $) In Millions, unless otherwise specified | 3 Months Ended | 6 Months Ended
--- | --- | ---
Jul. 01, 2012 | Jul. 03, 2011 | Jul. 01, 2012 | Jul. 03, 2011
Operating profit by segment of business |  |  |  |  |  |  |  |
Segments operating profit | $ 2,657 |  | $ 3,538 |  | $ 7,788 |  | $ 8,264 |
Percent Change | (24.90%) |  |  |  | (5.80%) |  |  |
Worldwide income before taxes | 2,035 |  | 3,422 |  | 7,080 |  | 7,932 |
Worldwide total, percent total | (40.50%) |  |  |  | (10.70%) |  |  |
Consumer [Member] |  |  |  |  |  |  |  |
Operating profit by segment of business |  |  |  |  |  |  |  |
Segments operating profit | 267 | [1] | 549 | [1] | 729 | [1] | 1,122 | [1]
Percent Change | (51.40%) | [1] |  |  | (35.00%) | [1] |  |
Pharmaceutical [Member] |  |  |  |  |  |  |  |
Operating profit by segment of business |  |  |  |  |  |  |  |
Segments operating profit | 515 | [2] | 1,714 | [2] | 3,106 | [2] | 3,923 | [2]
Percent Change | (70.00%) | [2] |  |  | (20.80%) | [2] |  |
Medical Devices and Diagnostics [Member] |  |  |  |  |  |  |  |
Operating profit by segment of business |  |  |  |  |  |  |  |
Segments operating profit | 1,875 | [3] | 1,275 | [3] | 3,953 | [3] | 3,219 | [3]
Percent Change | 47.10% | [3] |  |  | 22.80% | [3] |  |
Expense not allocated to segments [Member] |  |  |  |  |  |  |  |
Operating profit by segment of business |  |  |  |  |  |  |  |
Segments operating profit | $ (622) | [4] | $ (116) | [4] | $ (708) | [4] | $ (332) | [4]
[1] | Includes intangible asset write-downs of $294 million recorded in the fiscal second quarter and the first fiscal six months of 2012.
[2] | Includes litigation expense of $658 million, intangible asset write-downs of $499 million and in-process research and development charges of $429 million recorded in the fiscal second quarter and the first fiscal six months of 2012. Includes litigation expense of $290 million and $540 million recorded in the fiscal second quarter and the first fiscal six months of 2011, respectively.
[3] | Includes Synthes integration/transaction costs of $192 million and $223 million recorded in the fiscal second quarter and the first fiscal six months of 2012, respectively. Includes intangible asset write-downs of $146 million recorded in the fiscal second quarter and the first fiscal six months of 2012. Includes restructuring expense of $676 million recorded in the fiscal second quarter and the first fiscal six months of 2011. Includes litigation expense of $25 million and ASRTM Hip related costs of $102 million recorded in the fiscal second quarter of 2011. Includes litigation expense of $36 million and ASRTM Hip related costs of $187 million recorded in the first fiscal six months of 2011.
[4] | Amounts not allocated to segments include interest income/(expense), non-controlling interests and general corporate income/expense. Includes currency losses related to the Synthes acquisition of $382 million and $234 million recorded in the fiscal second quarter and the first fiscal six months of 2012, respectively, and litigation expense of $11 million recorded in the fiscal second quarter and the first fiscal six months of 2012, respectively. Includes a currency gain of $102 million related to the Synthes acquisition recorded in the fiscal second quarter and the first fiscal six months of 2011.

X
- Definition Percentage change in operating income loss. + References No definition available. + Details
Name: | jnj_PercentageChangeInOperatingIncomeLoss
Namespace Prefix: | jnj_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage change in operating income loss excluding expenses not allocated to segments. + References No definition available. + Details
Name: | jnj_PercentageChangeInOperatingIncomeLossExcludingExpensesNotAllocatedToSegments
Namespace Prefix: | jnj_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 4 -Section 08 -Paragraph h -Subparagraph 1(i) Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)(1)(i)) -URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690 + Details
Name: | us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The net result for the period of deducting operating expenses from operating revenues. + References No definition available. + Details
Name: | us-gaap_OperatingIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration